Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:03:51.862Z.
Calculation as of: 2026-10-06T16:03:51.862Z.
Quote observation: 2026-10-06T15:59:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: acb65a17080c98cb556e8dedfcd99ff418fc0d96cba63b9d245ba9f7ac680701
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$12.12M
Free Cash Flow Yield
N/A
TTM Avg
10.32%
3Y Avg
10.32%
5Y Avg
10.32%
Market Cap
$12.60M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.56M
Free Cash Flow Yield
N/A
TTM Avg
21.63%
3Y Avg
21.63%
5Y Avg
21.63%
Market Cap
$12.86M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.82M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | $12.71M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.12M | N/A | 10.32% | 10.32% | 10.32% |
| Cytosorbents Corporation (CTSO)vs › | $12.60M | N/A | N/A | N/A | N/A |
| Dare Bioscience, Inc. (DARE)vs › | $12.56M | N/A | 21.63% | 21.63% | 21.63% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | N/A | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG)vs › | $12.92M | N/A | N/A | N/A | N/A |
| Optimi Health Corp. (OPTH)vs › | $13.27M | N/A | N/A | N/A | N/A |
| IN8bio, Inc. (INAB)vs › | $13.71M | N/A | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.82M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.83M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
